Akira Yoshida
Nippon Medical School, Tokyo Medical and Dental University
Research areas: Medicine · Rheumatology · Inflammatory Myopathies and Dermatomyositis · Systemic Sclerosis and Related Diseases · Myasthenia Gravis and Thymoma
0000-0003-3590-1637
About
Dr. Akira Yoshida is a rheumatologist and clinician-scientist, currently working as a research associate in Department of Allergy and Rheumatology at Nippon Medical School, Tokyo, Japan. His research focuses on the pathophysiology of myositis, particularly anti-MDA5 antibody-positive dermatomyositis. He has a specific interest in immune mechanisms underlying rapidly progressive interstitial lung disease and disease heterogeneity. Dr. Yoshida is a core member of the Classification Criteria for Anti-Synthetase Syndrome (CLASS) project and the Myositis Clinical Trials Consortium (MCTC), contributing to international collaborative research aimed at improving disease classification stratification and clinical outcomes in myositis.
Employment
-
Nippon Medical School Research associate2025 - Present
Education
- 2019 - 2025
- 2008 - 2014
Projects & Funding
-
Can IFN-λ3 Be a Novel Therapeutic Target in Anti-MDA5 Antibody-Positive Interstitial Lung Disease? Japan Society for the Promotion of Science2026 - 2028
-
EULAR 2024 Congress Abstract Bursary Winner The European Alliance of Associations for Rheumatology
-
Rheumatology (Oxford) top 15 peer reviewers of 2025 British Society for Rheumatology
Publications (29)
- Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases and impact on survival Save
- Interlaboratory comparison of immunoprecipitation-based testing for myositis-specific autoantibodies Save
- Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group Save
- Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies Save
- Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre Save
- Anti-synthetase Syndrome–Associated Interstitial Lung Disease: Clinical Features and Outcomes Compared with Other ILDs Save
- Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencing. Save
- Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis. Save
- Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC). Save
- Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project Save
- The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. Save
- Different phenotypic manifestations between Brazilian and Japanese anti-MDA5 antibody-positive dermatomyositis: an international tricentric longitudinal study. Save
- Reduced Health‐Related Quality of Life in Patients With Systemic Sclerosis: A Cross‐Sectional Analysis of PROMIS Global Health Data From the International COVAD‐2 e‐Survey Save
- The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis. Save
- Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset Save
- Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply Save
- Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis Save
- Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey Save
- Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Save
- Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease Save